C. Garra MD, David Touboul MD, F. Malecaze MD, F. Malet Md, J Kerautet MD, N. Sire MD, P Fournier MD
Show Description +
The authors discuss the use of corneal collagen crosslinking linking (CXL) as a therapeutic treatment for keratoconus and post-excimer laser ectasia. It is believed that progression of keratoconus can be stabilized by using an ultra-violet laser to excite photosensitive riboflavin diffused in the cornea, subsequently stiffening and flattening the cornea.
Posted: 5/27/2009
C. Garra MD, David Touboul MD, F. Malecaze MD, F. Malet Md, J Kerautet MD, N. Sire MD, P Fournier MD
The authors discuss the use of corneal collagen crosslinking linking (CXL) as a therapeutic treatment for keratoconus and post-excimer laser ectasia. It is believed that progression of keratoconus can be stabilized by using an ultra-violet laser to excite photosensitive riboflavin diffused in the cornea, subsequently stiffening and flattening the cornea.
Posted: 5/27/2009
Please log in to leave a comment.